Comparative Genomic Diversity, Gut Microbiota Modulation, and 28-Day Oral Tolerability of Limosilactobacillus reuteri ATA-LTC-Lr050600
Antioxidants · 20.11.2026 · 15 (11) · 1513
DOI: 10.3390/antiox15111513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 20.11.2026. Verfasst von Ertuğrul Osman Bursalıoğlu und 14 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The rational development of microbiota-targeted therapeutics requires a combined assessment of the physiological effects of candidate microorganisms on the host and their ecological effects on the gut microbiota. The present study evaluates the toxicological properties and gut microbiota-related effects of a newly identified microorganism, designated as the Limosilactobacillus reuteri ATA-LTC-Lr050600 strain. In the 28-day single-dose limit study, conducted using OECD Guideline 407 as the methodological framework, no consistent pattern of adverse effects was observed in terms of the evaluated biochemical parameters, organ weights, and macroscopic findings. The 16S rRNA gene sequencing of faecal samples revealed time-dependent changes in microbial diversity and taxonomic composition. While an increase was observed in the relative abundance of the Lactobacillus and Bifidobacterium genera, which are associated with lactate and acetate production, no such increase was detected in taxa associated with butyrate and propionate production. While alpha diversity indices demonstrated only limited changes following probiotic supplementation, beta diversity analysis did not reveal any statistically significant changes in the overall microbial community structure. Following the implementation of a correction for multiple comparisons, statistical significance was not maintained for any of the redox-related parameters. When all findings are evaluated collectively, the results provide complementary information regarding the characterisation of the toxicological profile and microbiota-related effects of the L. reuteri ATA-LTC-Lr050600 strain.
Zitieren
APA
Bursalıoğlu, E. O., Aslan, İ., Kalay, Ş., Kurt, A. A., Aliusta, R., Hamdemir, R., Yıldırım, G., Kurtuluş, Ş. Ö., Hacımustafaoğlu, F., Çakıcı, B., Özkan, B. C., Bülbül, A. R., Boyama, B. A., Hacımustafaoğlu, A., & Mahmuljin, I. (2026). Comparative Genomic Diversity, Gut Microbiota Modulation, and 28-Day Oral Tolerability of Limosilactobacillus reuteri ATA-LTC-Lr050600. Antioxidants, 15(11), 1513. https://doi.org/10.3390/antiox15111513
Vancouver
Bursalıoğlu EO, Aslan İ, Kalay Ş, Kurt AA, Aliusta R, Hamdemir R, et al. Comparative Genomic Diversity, Gut Microbiota Modulation, and 28-Day Oral Tolerability of Limosilactobacillus reuteri ATA-LTC-Lr050600. Antioxidants. 2026;15(11):1513. doi:10.3390/antiox15111513
BibTeX
@article{Bursalolu2026,
author = {Bursalıoğlu, Ertuğrul Osman and Aslan, İsmail and Kalay, Şaban and Kurt, Ahmet Arif and Aliusta, Reyhan and Hamdemir, Rana and Yıldırım, Gamze and Kurtuluş, Şükran Özdatlı and Hacımustafaoğlu, Fatih and Çakıcı, Bekir and Özkan, Batuhan Cenk and Bülbül, Abdurrahman Recep and Boyama, Burcu Aydın and Hacımustafaoğlu, Ayşenur and Mahmuljin, Irma},
title = {Comparative Genomic Diversity, Gut Microbiota Modulation, and 28-Day Oral Tolerability of Limosilactobacillus reuteri ATA-LTC-Lr050600},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {11},
pages = {1513},
doi = {10.3390/antiox15111513}
}
EUVIMED